194 related articles for article (PubMed ID: 9400786)
1. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group.
Arch Ophthalmol; 1997 Dec; 115(12):1528-36. PubMed ID: 9400786
[TBL] [Abstract][Full Text] [Related]
2. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
[TBL] [Abstract][Full Text] [Related]
3. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
4. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.
Jabs DA; Gilpin AM; Min YI; Erice A; Kempen JH; Quinn TC;
AIDS; 2002 Apr; 16(6):877-87. PubMed ID: 11919489
[TBL] [Abstract][Full Text] [Related]
5. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
[TBL] [Abstract][Full Text] [Related]
6. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
[TBL] [Abstract][Full Text] [Related]
8. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
[TBL] [Abstract][Full Text] [Related]
9. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
10. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Boeckh M; Bowden RA; Storer B; Chao NJ; Spielberger R; Tierney DK; Gallez-Hawkins G; Cunningham T; Blume KG; Levitt D; Zaia JA
Biol Blood Marrow Transplant; 2001; 7(6):343-51. PubMed ID: 11464977
[TBL] [Abstract][Full Text] [Related]
14. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
[TBL] [Abstract][Full Text] [Related]
16. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy.
Holbrook JT; Jabs DA; Weinberg DV; Lewis RA; Davis MD; Friedberg D;
Arch Ophthalmol; 2003 Jan; 121(1):99-107. PubMed ID: 12523893
[TBL] [Abstract][Full Text] [Related]
17. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
Gangaputra S; Drye L; Vaidya V; Thorne JE; Jabs DA; Lyon AT;
Am J Ophthalmol; 2013 Feb; 155(2):206-212.e5. PubMed ID: 23068916
[TBL] [Abstract][Full Text] [Related]
18. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis.
Jabs DA; Martin BK; Forman MS; Ricks MO;
J Infect Dis; 2005 Aug; 192(4):640-9. PubMed ID: 16028133
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
